Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

IMS 2024 | The clinicopathological characteristics of patients with POEMS syndrome

Oliver Tomkins • 27 Sep 2024

IMS 2024

POEMS Syndrome Rare Diseases

In this video, Oliver Tomkins, BMBS, BMedSci, DTMH, MRCP(UK), FRCPath, University College London Hospitals NHS Foundation Trust, London, UK, discusses a poster that outlined the clinicopathological characteristics of patients with POEMS syndrome. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

$Systemic treatment outcomes in relapsed/refractory POEMS syndrome$ 0:49

Systemic treatment outcomes in relapsed/refractory POEMS syndrome

Oliver Tomkins • 27 Sep 2024

POEMS syndrome: patient presentation and advice for physicians managing patients

POEMS syndrome: patient presentation and advice for physicians managing patients

Oliver Tomkins • 27 Sep 2024

Frontline systemic treatment outcomes in patients with POEMS syndrome

Frontline systemic treatment outcomes in patients with POEMS syndrome

Oliver Tomkins • 27 Sep 2024

Related Videos

Refining the diagnosis and classification of CMML

Refining the diagnosis and classification of CMML

Guillermo Montalban-Bravo et al. • 20 Sep 2025

Improving the diagnosis of amyloidosis: advice that can be applied in practice

Improving the diagnosis of amyloidosis: advice that can be applied in practice

Gareth Morgan • 18 Sep 2025

Ongoing research in gray zone lymphoma

Ongoing research in gray zone lymphoma

Kieron Dunleavy • 4 Sep 2025

Insights into gray zone lymphoma: a rare subtype of NHL

Insights into gray zone lymphoma: a rare subtype of NHL

Kieron Dunleavy • 4 Sep 2025